Research and Markets: Funded Research in Fibroid Tumors (Uterine)

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/r9xlf8/funded_research) has announced the addition of the "Funded Research in Fibroid Tumors (Uterine)" report to their offering.

This report will provide global transparency to research funded for Fibroid Tumors (Uterine) - based on models of NIH definitions for those topic areas.

Using these models, we will provide you with 5 years of Fibroid Tumors (Uterine) Grant Funding data from the top global funders of Science Research - representing over 80 different funding organizations worldwide.

Key Questions Answered

  • Which global funders are providing the most resources in Fibroid Tumors (Uterine)?
  • Which institutions are receiving the most awards?
  • Which investigators are leading the field in new and current funding/projects?
  • What funds have been targeted in this field for future years (projects won in 2013, 2014 which will fund for the next 2-3 years)

This is the most forward-looking and current research data source on Fibroid Tumors (Uterine).

Funding includes 5 years of data from the major science and biomedical funders in Europe, North America, and Australia.

For more information visit http://www.researchandmarkets.com/research/r9xlf8/funded_research

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices